Literature DB >> 25758215

Anterior cruciate ligament- and hamstring tendon-derived cells: in vitro differential properties of cells involved in ACL reconstruction.

Corina Adriana Ghebes1, Cindy Kelder1, Thomas Schot1, Auke J Renard2, Dean F M Pakvis3, Hugo Fernandes1,4, Daniel B Saris1,5.   

Abstract

Anterior cruciate ligament (ACL) reconstruction involves the replacement of the torn ligament with a new graft, often a hamstring tendon (HT). Described as similar, the ACL and HT have intrinsic differences related to their distinct anatomical locations. From a cellular perspective, identifying these differences represents a step forward in the search for new cues that enhance recovery after the reconstruction. The purpose of this study was to characterize the phenotype and multilineage potential of ACL- and HT-derived cells. ACL- and HT-derived cells were isolated from tissue harvest from patients undergoing total knee arthroplasty (TKA) or ACL reconstruction. In total, three ACL and three HT donors were investigated. Cell morphology, self-renewal potential (CFU-F), surface marker profiling, expression of tendon/ligament-related markers (PCR) and multilineage potential were analysed for both cell types; both had fibroblast-like morphology and low self-renewal potential. No differences in the expression of tendon/ligament-related genes or a selected set of surface markers were observed between the two cell types. However, differences in their multilineage potential were observed: while ACL-derived cells showed a high potential to differentiate into chondrocytes and adipocytes, but not osteoblasts, HT-derived cells showed poor potential to form adipocytes, chondrocytes and osteoblasts. Our results demonstrated that HT-derived cells have low multilineage potential compared to ACL-derived cells, further highlighting the need for extrinsic signals to fully restore the function of the ACL upon reconstruction.
Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Anterior Cruciate Ligament reconstruction; Anterior Cruciate Ligament-derived cells; Hamstring Tendon-derived cells; multilineage potential

Mesh:

Substances:

Year:  2015        PMID: 25758215     DOI: 10.1002/term.2009

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  4 in total

Review 1.  Stem cell therapy: a promising biological strategy for tendon-bone healing after anterior cruciate ligament reconstruction.

Authors:  Zi-Chen Hao; Shan-Zheng Wang; Xue-Jun Zhang; Jun Lu
Journal:  Cell Prolif       Date:  2016-03-01       Impact factor: 6.831

2.  Anterior cruciate ligament-derived mesenchymal stromal cells have a propensity to differentiate into the ligament lineage.

Authors:  Yusuke Ogata; Yo Mabuchi; Kosuke Shinoda; Yuta Horiike; Mitsuru Mizuno; Koji Otabe; Eriko Grace Suto; Nobuharu Suzuki; Ichiro Sekiya; Chihiro Akazawa
Journal:  Regen Ther       Date:  2018-01-23       Impact factor: 3.419

3.  Enhancement of in vitro proliferation and bioactivity of human anterior cruciate ligament fibroblasts using an in situ tissue isolation method and basic fibroblast growth factor culture conditions: A pilot analysis.

Authors:  Ziming Liu; Yuwan Li; Youliang Ren; Ying Jin; Jibin Yang; Shengmin Wang; Xizhong Zhu; Huazhang Xiong; Gang Zou; Yi Liu; Wei Huang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

4.  Management of Anterior Cruciate Ligament Injury: What's In and What's Out?

Authors:  Benjamin Todd Raines; Emily Naclerio; Seth L Sherman
Journal:  Indian J Orthop       Date:  2017 Sep-Oct       Impact factor: 1.251

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.